High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples
about
Multiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosisLong Non-Coding RNAs: The Key Players in Glioma PathogenesisKAP1 regulates gene networks controlling T-cell development and responsiveness.DNMT3A Mutations in Acute Myeloid LeukemiaCRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopmentRelationship between expression and methylation of obesity-related genes in childrenThe origin and evolution of mutations in acute myeloid leukemiaGenomic and epigenomic landscapes of adult de novo acute myeloid leukemia.T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas.Comparison of Nanostring nCounter® Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemiaA phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.Pathway-specific analysis of gene expression data identifies the PI3K/Akt pathway as a novel therapeutic target in cervical cancer.Long intergenic non-coding RNA HOTAIRM1 regulates cell cycle progression during myeloid maturation in NB4 human promyelocytic leukemia cells.PU.1 is linking the glycolytic enzyme HK3 in neutrophil differentiation and survival of APL cells.Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells.DSCR9 gene simultaneous expression in placental, testicular and renal tissues from baboon (Papio hamadryas).Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemiaA multiplex assay to measure RNA transcripts of prostate cancer in urine.Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA miceUsing digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias.Identification of KIF5B-RET and GOPC-ROS1 fusions in lung adenocarcinomas through a comprehensive mRNA-based screen for tyrosine kinase fusions.PML-RARA can increase hematopoietic self-renewal without causing a myeloproliferative disease in mice.Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progressionPrognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemiaExpression and role of RIP140/NRIP1 in chronic lymphocytic leukemia.Differential niche and Wnt requirements during acute myeloid leukemia progressionAnnexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.Dkk1 haploinsufficiency requires expression of Bmp2 for bone anabolic activityEstablishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cells.New strategies in hepatocellular carcinoma: genomic prognostic markers.Multiplexed digital quantification of binge-like alcohol-mediated alterations in maternal uterine angiogenic mRNA transcriptome.A critical appraisal of tools available for monitoring epigenetic changes in clinical samples from patients with myeloid malignancies.Transcriptional repression of CDKN2D by PML/RARα contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells.Gene and protein analysis reveals that p53 pathway is functionally inactivated in cytogenetically normal Acute Myeloid Leukemia and Acute Promyelocytic LeukemiaMeta-analysis approach as a gene selection method in class prediction: does it improve model performance? A case study in acute myeloid leukemia4‑Phenylbutyrate protects rat skin flaps against ischemia‑reperfusion injury and apoptosis by inhibiting endoplasmic reticulum stress.Genomic impact of transient low-dose decitabine treatment on primary AML cellsPhase II clinical and exploratory biomarker study of dacomitinib in recurrent and/or metastatic esophageal squamous cell carcinoma.
P2860
Q23918758-3FF29F9E-348A-4B82-B945-636FA4AF1263Q26800873-8E6B514B-5177-41BA-9BD7-E2122D74128FQ27319505-F9BC70CD-D783-4BA1-94CF-291050FB128AQ27559610-C5C302FD-D3E8-45EE-96D5-CDE64E70578BQ28391523-FC103C70-BDB2-4F51-A359-AF5932181261Q28393499-97260CC1-C325-462D-AF15-217E4FF9B4D2Q29614630-46518682-489A-448F-9D5B-D21AD0F59A31Q29615735-1EFA564D-F5EE-47D6-8B51-B07B66B4CE51Q30491565-E00DF96D-8BDC-4599-90B4-0B61AD06BF06Q31095892-E56CDA88-38C2-482A-B8D2-741331D8E478Q33746724-F9085085-906B-44F1-97F3-08C1897C6F0BQ33939624-3D2EFCBB-327B-4A22-B346-3D551F74F8A4Q34123402-41CDABB6-8B06-43CD-BC8A-59945F137769Q34143034-B9CBDA39-77C8-4DA9-A353-6DAC95C370FAQ34267963-4476B52C-1A2E-4903-9C69-EB12C5FE9F81Q34270770-F72BF3FD-637E-4726-B24F-2E3A2DC4DCDEQ34306604-EF5523DA-8AC5-4BC9-B056-D0FD0758E0C8Q34340593-5D998D67-43E1-4FDB-8CA9-0BFFBAD5517EQ34429720-7E5E6EE6-DD9A-4481-85B3-7BF580E48375Q34441594-8D524A80-AB88-4774-9BD8-A002DCB8B6CCQ34477671-2728E932-1244-4DA9-9F48-2CEB7F1E48C1Q34522899-36FE7829-A790-4DBD-8625-07BD555A29DCQ34749039-BB218A8F-BAC9-44EB-BDA8-400249D0A348Q34755408-C502209E-2D5F-46E7-B2F8-2C91EB8789F2Q35152173-5AC6C23D-40DD-40AD-B228-079D88C9BEE5Q35162589-D1FE1AD6-F795-4588-BF0A-C26C3D3BB052Q35212397-7CA5F7FC-341C-4B28-9343-5758C9AC0633Q35213733-B894F342-DC4D-4376-A2A8-DAACA4B689C3Q35287547-19237CE3-D07D-4576-AD6D-DE0B7A6B4D1BQ35391634-95A7F9D1-91CE-4FD3-9E9D-34DDB4C421BBQ35592507-BF130F63-F03A-4C32-9608-4DC3D1BFB01EQ36090222-37D6595C-1C34-463B-9DF0-60D670FFDE46Q36185501-8B2FBE09-03E2-4A45-9036-9CC1D7C73D2FQ36216230-997A6183-D73A-4952-94B9-723D7426A5A5Q36291101-CA54F599-8649-4060-9AD6-974902D336F9Q36322508-D165F56A-CC23-48B8-8730-7DF9E5C22E1AQ36343603-539D657B-F186-4173-B9CA-79AD32E949D8Q36520252-4124FBCA-CCF3-4DF8-A0F1-26309DDCBF14Q36654140-09629A07-5D79-4950-A6F0-85E2C08A39BEQ36689140-9AE0158C-8400-49DD-A453-97197108F9F2
P2860
High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samples
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
High throughput digital quanti ...... acute myeloid leukemia samples
@ast
High throughput digital quanti ...... acute myeloid leukemia samples
@en
High throughput digital quanti ...... acute myeloid leukemia samples
@nl
type
label
High throughput digital quanti ...... acute myeloid leukemia samples
@ast
High throughput digital quanti ...... acute myeloid leukemia samples
@en
High throughput digital quanti ...... acute myeloid leukemia samples
@nl
prefLabel
High throughput digital quanti ...... acute myeloid leukemia samples
@ast
High throughput digital quanti ...... acute myeloid leukemia samples
@en
High throughput digital quanti ...... acute myeloid leukemia samples
@nl
P2093
P2860
P3181
P356
P1476
High throughput digital quanti ...... acute myeloid leukemia samples
@en
P2093
Daniel C Link
Gary K Geiss
Jacqueline E Payton
Li-Wei Chang
Mark A Watson
Mark Murakami
Rakesh Nagarajan
Timothy J Ley
P2860
P304
P3181
P356
10.1172/JCI38248
P407
P577
2009-05-18T00:00:00Z